Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

CVS Health Corporation (CVS) had Revenue of $357.78B for the most recently reported fiscal year, ending 2023-12-31.

Quarterly Annual

Figures for fiscal year ending 2023-12-31

Income Statement Financials
Revenue	$357.78B
Net Income	$8.34B
Cost of Goods Sold	$217.10B
Gross Profit	$140.68B
Operating Expenses	$344.03B
Operating Income	$13.74B
Non-Operating Income/Expense	$-2.57B
Pre-Tax Income	$11.17B
Normalized Pre-Tax Income	$11.17B
Income after Taxes	$8.37B
Income from Continuous Operations	$8.37B
Consolidated Net Income/Loss	$8.37B
Normalized Income after Taxes	$8.37B
EBIT	$13.74B
EBITDA	$18.11B
Weighted-Average Shares Outstanding (Basic)	1.28B
Weighted-Average Shares Outstanding (Diluted)	1.29B
Earnings per Share (EPS) (Basic)	$6.49
Earnings per Share (EPS) (Diluted)	$6.47
Balance Sheet Financials
Current Assets	$67.86B
Property, Plant, and Equipment	$13.18B
Long-Term Assets	$181.87B
Total Assets	$249.73B
Current Liabilities	$79.19B
Long-Term Debt	$58.64B
Long-Term Liabilities	$93.90B
Total Liabilities	$173.09B
Common Equity	$76.64B
Tangible Shareholders Equity	$-43.87B
Shareholders Equity	$76.64B
Common Shares Outstanding	1.29B
Cash Flow Statement Financials
Cash Flow from Operating Activities	$13.43B
Cash Flow from Investing Activities	$-20.89B
Cash Flow from Financial Activities	$2.68B
Beginning Cash	$13.30B
End Cash	$8.53B
Increase/Decrease in Cash	$-4.78B
Stock-Based Compensation	$588.00M
Common Stock Dividends Paid	$-3.13B
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	0.86
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.43
Debt to Equity Ratio	0.80
Gross Margin	39.32%
Operating Margin	3.84%
EBIT Margin	3.84%
EBITDA Margin	5.06%
Pre-Tax Profit Margin	3.12%
Profit Margin	2.33%
Free Cash Flow	$10.39B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	1.43
Inventory Turnover	12.04
Receiveable Turnover	10.16
Days Sales in Receivables	35.94
Return on Equity	10.92%
Return on Tangible Equity	-19.07%
Return on Assets	3.35%
Return on Investments	6.19%
Book Value Per Share	$59.50
Free Cash Flow per Share	$8.06
Operating Cash Flow per Share	$10.41

Data from Zacks Investment Research, Inc.